Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Total Debt (2016 - 2026)

Cryo Cell International's Total Debt history spans 17 years, with the latest figure at $2.5 million for Q1 2026.

  • Quarterly results put Total Debt at $2.5 million for Q1 2026, down 54.55% from a year ago — trailing twelve months through Feb 2026 was $2.5 million (down 54.55% YoY), and the annual figure for FY2025 was $3.2 million, down 73.16%.
  • Total Debt for Q1 2026 was $2.5 million at Cryo Cell International, down from $3.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $12.6 million in Q2 2024 to a low of $875000.0 in Q1 2022.
  • The 5-year median for Total Debt is $3.6 million (2023), against an average of $5.9 million.
  • Peak annual rise in Total Debt hit 1074.68% in 2023, while the deepest fall reached 80.67% in 2023.
  • Year by year, Total Debt stood at $10.9 million in 2022, then crashed by 80.67% to $2.1 million in 2023, then soared by 463.95% to $11.8 million in 2024, then crashed by 73.16% to $3.2 million in 2025, then dropped by 22.05% to $2.5 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods came in at $2.5 million, $3.2 million, and $11.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.